Healthcare


 REG Acquires Two Melbourne Aged Care Facilities for $35.5 Million

REG Acquires Two Melbourne Aged Care Facilities for $35.5 Million

September 20, 2024 03:07 PM AEST| By Team Kalkine Media

Regis Healthcare Limited (ASX: REG), a leading provider of aged care services in Australia, has announced the acquisition of two aged care facilities in Melbourne from Ti Tree Operations for $35.5 million. This strategic acquisition, funded entirely...

 CSL Ltd (ASX:CSL) Announces Leadership Changes: John Levy Steps in as Interim CFO

CSL Ltd (ASX:CSL) Announces Leadership Changes: John Levy Steps in as Interim CFO

September 20, 2024 02:27 PM AEST| By Team Kalkine Media

CSL Ltd (ASX:CSL), a global leader in biotechnology, has announced significant leadership changes within its financial department. John Levy will assume the role of Interim Chief Financial Officer (CFO), while Joy Linton, the outgoing CFO, transition...

 Health Check: Cann Group Experiences Earnings Turnaround Amidst Challenges

Health Check: Cann Group Experiences Earnings Turnaround Amidst Challenges

September 20, 2024 01:13 AM AEST| By Team Kalkine Media

Cann Group (ASX: CAN), a pioneer in the medical cannabis sector, is signaling a turnaround after facing significant challenges. The company, which posted a $13.2 million loss for the 2023-24 financial year, is targeting a return to underlying earning...

 ResMed Shares Take a Hit on Thursday. Here’s Why.

ResMed Shares Take a Hit on Thursday. Here’s Why.

September 19, 2024 03:32 PM AEST| By Team Kalkine Media

Shares of ResMed (ASX:RMD) are experiencing a significant decline on Thursday, with the stock down 3.5% to AU$34.98 after opening at AU$35.30, compared to yesterday's close of $36.25. This downturn is notable against the backdrop of a generally rough...

 Key Reasons to Keep an Eye on CSL Ltd and Pro Medicus Shares

Key Reasons to Keep an Eye on CSL Ltd and Pro Medicus Shares

September 19, 2024 03:23 PM AEST| By Team Kalkine Media

Since the beginning of 2024, shares of CSL Ltd have risen by 2.5%, while Pro Medicus Limited is trading just 1.3% away from its 52-week high. Let’s take a closer look at what’s driving interest in these two,ASX healthcare stocks,and why they could be...

 Surge in Yoghurt Sales Boosts Bega's Market Value

Surge in Yoghurt Sales Boosts Bega's Market Value

September 19, 2024 12:32 PM AEST| By Team Kalkine Media

Bega Cheese Limited (ASX: BGA), a major player in the Australian dairy industry, has experienced a significant increase in market capitalisation, adding approximately $700 million over the past nine months. This rise marks a return to valuation level...

 Ramsay Health Care Limited (ASX:RHC) Price-to-Earnings Ratio: A Closer Look

Ramsay Health Care Limited (ASX:RHC) Price-to-Earnings Ratio: A Closer Look

September 19, 2024 10:30 AM AEST| By Team Kalkine Media

Ramsay Health Care Limited (ASX:RHC) currently holds a price-to-earnings (P/E) ratio of 36.3x, significantly higher than the market average in Australia, where nearly half of the listed companies trade below a P/E ratio of 19x. On the surface, this e...

 Does LuPSMA Represent a Breakthrough in Treating Metastatic Prostate Cancer?

Does LuPSMA Represent a Breakthrough in Treating Metastatic Prostate Cancer?

September 18, 2024 04:20 PM AEST| By Team Kalkine Media

A significant study conducted by the,Peter MacCallum Cancer Centre,(Peter Mac) has demonstrated the potential of targeted radioactive infusion for enhancing treatment outcomes in metastatic prostate cancer, with implications for earlier-stage disease...

 FDA Provides Guidance for Paradigm Biopharma's Phase 3 Osteoarthritis Trial: A Closer Look

FDA Provides Guidance for Paradigm Biopharma's Phase 3 Osteoarthritis Trial: A Closer Look

September 18, 2024 10:27 AM AEST| By Team Kalkine Media

Paradigm Biopharmaceuticals (ASX:PAR) has received significant feedback from the U.S. Food and Drug Administration (FDA) regarding its Phase 3 clinical trial for knee osteoarthritis. The FDA's recent communication highlights a need for adjustments to...

 Botanix Pharmaceuticals Ltd (ASX: BOT) to Launch Sofdra for Excessive Sweating in the US

Botanix Pharmaceuticals Ltd (ASX: BOT) to Launch Sofdra for Excessive Sweating in the US

September 17, 2024 06:09 PM AEST| By Team Kalkine Media

Botanix Pharmaceuticals Ltd (ASX: BOT) has announced an upcoming launch of its approved product, Sofdra, for treating primary axillary hyperhidrosis (PAH), a condition causing excessive sweating. The product is expected to hit the US market in the Ma...

 Pacific Smiles Group (ASX:PSQ) Receives New Takeover Offer from Beam Dental Bidco

Pacific Smiles Group (ASX:PSQ) Receives New Takeover Offer from Beam Dental Bidco

September 17, 2024 10:37 AM AEST| By Team Kalkine Media

Pacific Smiles Group Ltd (ASX:PSQ), a prominent dental centre operator in Australia, has recently received an off-market takeover proposal from Beam Dental Bidco Pty Ltd, an unlisted Australian entity. Beam Dental Bidco is associated with Genesis Cap...

 Dimerix (ASX: DXB) Partners with UK’s RaDaR to Advance FSGS Treatment

Dimerix (ASX: DXB) Partners with UK’s RaDaR to Advance FSGS Treatment

September 16, 2024 08:23 PM AEST| By Team Kalkine Media

Dimerix,(ASX: DXB),has recently announced a significant collaboration with the UK’s National Registry of Rare Kidney Diseases (RaDaR) to enhance its ACTION3 Phase 3 clinical trial for DMX-200, aimed at treating focal segmental glomerulosclerosis (FSG...

 ResMed CDI (ASX: RMD) Sees Strong 2024 Performance: A Closer Look

ResMed CDI (ASX: RMD) Sees Strong 2024 Performance: A Closer Look

September 16, 2024 06:10 PM AEST| By Team Kalkine Media

The share price of ResMed CDI,(ASX: RMD),has surged by 45.3% since the beginning of 2024. This substantial increase has drawn attention to the company’s performance and potential.,RMD Share Price Overview,Founded in 1989 by Peter Farrell, ResMed orig...

 Regis Healthcare Ltd (ASX: REG) Sees Impressive Gains: What Does the Price-to-Sales Ratio Reveal?

Regis Healthcare Ltd (ASX: REG) Sees Impressive Gains: What Does the Price-to-Sales Ratio Reveal?

September 13, 2024 02:23 PM AEST| By Team Kalkine Media

Regis Healthcare Ltd,(ASX: REG),has seen a remarkable 31% increase in its share price over the past month, contributing to an impressive 112% annual gain. This surge has certainly caught the attention of investors.,Despite this strong performance, th...

 BlinkLab (ASX: BB1) Partners with INTER-PSY to Advance Autism Diagnosis

BlinkLab (ASX: BB1) Partners with INTER-PSY to Advance Autism Diagnosis

September 12, 2024 06:33 PM AEST| By Team Kalkine Media

BlinkLab has embarked on a significant partnership with INTER-PSY to advance the capabilities of its autism diagnostic platform. This collaboration aims to optimize BlinkLab's experimental and AI algorithms, facilitating the path to regulatory approv...

 CSL Ltd (ASX: CSL) Shares Up 4% in 2024: Should They Be on Your Radar?

CSL Ltd (ASX: CSL) Shares Up 4% in 2024: Should They Be on Your Radar?

September 12, 2024 02:42 PM AEST| By Team Kalkine Media

CSL Ltd has seen its share price climb 4.0% since the beginning of 2024. As an,ASX healthcare stock,, this rise reflects the company’s ongoing commitment to developing innovative medicines that address critical health needs and contribute to improved...

 GTI extends uranium mineralisation at Lo Hema through development drilling

GTI extends uranium mineralisation at Lo Hema through development drilling

September 12, 2024 01:18 PM AEST| By Team Kalkine Media

Clarity Pharmaceuticals Ltd (ASX:CU6) has announced progress in its ongoing SECuRE trial, with positive safety results from the latest stage. The trial focuses on prostate cancer treatment using Cu-SAR-bisPSMA, targeting prostate-specific membrane an...

 Dimerix Begins Phase 3 Recruitment for Kidney Disease Study in Mexico

Dimerix Begins Phase 3 Recruitment for Kidney Disease Study in Mexico

September 12, 2024 11:15 AM AEST| By Team Kalkine Media

Dimerix Limited (ASX:DXB) has announced the commencement of patient recruitment for its ‘ACTION3’ Phase 3 clinical trial. This significant milestone involves enrolling adolescent patients aged 12 to 17 with kidney disease in Mexico. The selection of...

 Pro Medicus Limited (ASX: PME): Why the Surge in Share Price?

Pro Medicus Limited (ASX: PME): Why the Surge in Share Price?

September 10, 2024 02:13 PM AEST| By Team Kalkine Media

The Pro Medicus Limited,(ASX: PME),share price has experienced a remarkable 63.6% increase since the beginning of 2024. This impressive rise in value highlights the growing interest in PME shares and raises the question of what is driving this surge....

 Noxopharm Obtains $1.8 Million in Funding Ahead of R&D Rebate

Noxopharm Obtains $1.8 Million in Funding Ahead of R&D Rebate

September 09, 2024 02:19 PM AEST| By Team Kalkine Media

Noxopharm Ltd,(ASX:NOX),has secured $1.8 million in advanced funding through a secured loan agreement with Endpoints Capital Pty Ltd, a specialist in R&D finance for the life sciences sector. This loan is backed by an anticipated rebate from the Aust...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.